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O B J E C T I V E S The aim of this study was to evaluate the feasibility and acute efﬁcacy of real-time
3-dimensional transesophageal echocardiography (RT3DTEE)–guided ablation of the cavotricuspid isthmus (CVTI).
B A C KG ROUND The use of RT3DTEE to guide a transcatheter radiofrequency ablation procedure
has never been systematically investigated.
METHOD S Seventy consecutive patients with CVTI-dependent atrial ﬂutter underwent CVTI ablation.
Procedural monitoring using RT3DTEE was assigned to patients who requested general anesthesia for the
procedure (n 21 [30%]). In the other 49 patients (the control group), the procedures were monitored using
the standard ﬂuoroscopic approach. Procedural time was considered as skin-to-skin electrophysiological
procedure duration, not including anesthesia preparation; adequate radiofrequency ablation applications
(with ﬁxed temperature and power settings) were considered as lesions lasting  60 s.
R E S U L T S RT3DTEE allowed visualization of the CVTI and identiﬁed related structures in most patients
(20 of 21); anatomic features such as long CVTI (n  11), prominent Eustachian ridge (n  9), prominent
Eustachian valve (n 6), septal recess (n 8), and pectinate muscles (n 10) were frequent. Also, RT3DTEE
allowed continuous visualization of ablation catheter movement and contact. Compared with the control
group, RT3DTEE was equally effective in achieving CVTI bidirectional block (100% in both groups), and no
complications occurred. RT3DTEE shortened procedural time (median 73.0 min, interquartile range [IQR] 60.0
to 90.0 min, vs. median 115.0 min, IQR 85.0 to 133.0 min, p  0.001), reduced radiation exposure (median
ﬂuoroscopy time 4.2 min, IQR 3.1 to 8.4 min, vs. median 19.3 min, IQR 12.9 to 36.4 min, p  0.001; median
ﬂuoroscopy dose 575.4 cGy · cm2, IQR 428.5 to 1,299.4 cGy · cm2, vs. median 3,520.7 cGy · cm2, IQR 1,700.0
to 6,709.0 cGy · cm2, p  0.001), and reduced the number of radiofrequency applications to achieve
bidirectional block (median 7, IQR 6 to 10, vs. median 12, IQR 10 to 22, p  0.007). A strong learning curve
was detected by comparing procedural data between the ﬁrst and last patients treated using RT3DTEE.
CONC L U S I O N S RT3DTEE-guided ablation of CVTI was feasible, allowing real-time detailed morpho-
logical CVTI characterization as well as continuous visualization of the ablation catheter during radiofre-
quency ablation. This approach entailed marked reductions in procedural time, radiation exposure, and the
number of radiofrequency applications. (J Am Coll Cardiol Img 2011;4:716–26) © 2011 by the American
College of Cardiology Foundation
From the *Division of Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland; and the †Service of Biometry and
Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Dr. Faletra has received speaking fees from
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717adiofrequency ablation (RFA) of the cavotri-
cuspid valve isthmus (CVTI) is a widely
applied, highly successful nonpharmacologi-
cal therapy for atrial flutter (1,2). It is well
ecognized, however, that varying anatomical and
orphological aspects of the CVTI may at times
ender conduction block across the CVTI through
atheter ablation difficult, thus resulting in pro-
onged ablation and fluoroscopy times or even
rocedural failure. Continued efforts have therefore
een oriented toward developing further innovative
blative (3,4) and mapping (5,6) strategies as well as
maging modalities (7) to ensure incremental pro-
edural success while reducing procedural duration
See page 727
and risk; also, procedure-related biological risk by
prolonged exposure to ionization radiation repre-
sents a growing concern (8).
Real-time 3-dimensional transesophageal echocar-
diography (RT3DTEE) is a recently developed tech-
nique that provides 3-dimensional images of unprec-
edented quality. Because the right atrium is close to
the transducer, this allows visualization of morphology
and anatomy with great detail, as outlined in a recent
contribution (9). In the specific context of CVTI
ablation, RT3DTEE may help accurately characterize
anatomical barriers limiting efficacious RFA delivery.
Although RT3DTEE monitoring of pulmonary vein
isolation procedure has been reported anecdotally
(10), whether RT3DTEE may precisely delineate the
CVTI and be suitable for guiding ablation in this
region has not been demonstrated so far.
Therefore, the objectives of the present study were
3-fold: 1) to assess the feasibility of RT3DTEE to
image the CVTI and evaluate the ability to navigate
with the mapping catheter within the CVTI region;
2) to verify the acute efficacy of RT3DTEE-guided
CVTI ablation by comparison with the conventional
fluoroscopy-guided approach; and 3) to evaluate po-
tential reductions of radiation exposure using
RT3DTEE.
M E T H O D S
Patient population. This was a single-center, pro-
spective, observational study including consecutive
Biosense Webster, BDS Cordis, Philips, Impulse Dynamics, and has re
Biotronik, St. Jude Medical, and Abbott. All other authors have reporteManuscript received October 10, 2010; revised manuscript received March 7patients presenting electrocardiographically docu-
mented typical atrial flutter who underwent RFA of
the CVTI at Cardiocentro Ticino (Lugano, Swit-
zerland). After obtaining patients’ written and oral
consent to the procedure, and at patients’ request,
RFA was carried out either with or without deep
sedation. When under general anesthesia, patients
were monitored using RT3DTEE. Patients in
whom CVTI RFA had previously failed or who
presented associated atrial tachyarrhythmias with
common atrial flutter (atrial fibrillation, atrial ar-
rhythmias, re-entry tachycardia, and so on), were
excluded from the study. Between January 2009 and
November 2010, 70 consecutive patients underwent
isolated, first-time CVTI-dependent atrial flutter
ablation. Twenty-one patients (30%) requested
general anesthesia (the RT3DTEE group). Patients
in whom CVTI ablation was carried out according
to the fluoroscopy-based approach represented the
control group.
CVTI ablation procedure. In all patients, antiarrhyth-
mic drugs as well as oral anticoagulation
therapy were discontinued before the ab-
lation procedure. The ablation procedure
was conducted by positioning 2 standard
decapolar deflectable catheters via the
femoral vein along the right atrial free wall
and another in the coronary sinus. A
conventional 8-mm mapping ablation
catheter was then used. Intracavitary dig-
italized electrograms and 12-lead surface
electrocardiograms were recorded and dis-
played on a multichannel recorder and
stored on magneto-optical discs (Prucka Cardio-
Lab; GE Marquette Medical Systems, Milwaukee,
Wisconsin). RFA was performed with either EPT-
1000 XP (EP Technologies, Mountain View, Cal-
ifornia) or Cordis-Stockert (Cordis-Webster, Mi-
ami Lakes, Florida) radiofrequency (RF)
generators, allowing the delivery of continuous,
unmodulated current, with power output set at 80
W and a pre-set temperature of 65°C. The end
point of the ablation procedure was the achieve-
ment of complete bidirectional CVTI block
(11,12), persisting for a waiting period of 30 min.
The following procedural data were collected:
total procedural time, total RF application time and
number of RF applications (applications  60 s in
ed speaker fees from Sorin Group, Medtronic,
at they have no relationships to disclose.
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718duration [5]), fluoroscopy time, and cumulative
exposure dose. Procedural time in the RT3DTEE
group did not include anesthesia preparation time
but was limited to the duration of the electrophys-
iological procedure.
Real-time 3-dimensional transesophageal echocardio-
graphic acquisition and analysis. RT3DTEE was
erformed using a commercially available fully sam-
led matrix-array transesophageal echocardiographic
ransducer and ultrasound system (X7-2t Live 3D
ransducer, iE33; Philips Medical Systems, Andover,
assachusetts). First, a real-time 3-dimensional im-
ge from the 2-dimensional 4-chamber plane was
btained, using a pyramidal dataset large enough to
nclude the entire right atrium. Subsequently, by using
he auto-crop function, the anterior half of the atrium
as removed, and an arbitrary crop was applied to
emove remaining nonrelevant anatomic structures.
he image was then rotated to provide a perspective
imilar to the fluoroscopic left anterior oblique view
Fig. 1). From this position, a slight clockwise
otation and a deeper cut of the frontal plane were
pplied to provide a perspective similar to the
uoroscopic right anterior oblique view. Both views
llowed evaluation of the length of the CVTI and
he details of its anatomical features (Figs. 2 and 3).
Real-time images were viewed by both the echo-
cardiographer and the electrophysiologist during
the RFA procedure.
Figure 1. RT3DTEE and Fluoroscopic Views of the CVTI
Real-time 3-dimensional transesophageal echocardiography (RT3DT
mus (CVTI). AO  aorta; CS  coronary sinus; CVTI  cavotricuspid
RA  right atrium; RAO  right anterior oblique; SVC  superior venaQuantitative analysis of CVTI length was per-
formed offline using dedicated software (QLAB
Cardiac 3DQ; Philips Medical Systems). The mul-
tiplanar reconstruction mode of the software was
used to identify the exact extensions of the right
atrial myocardium for accurate CVTI length deter-
mination; the length of CVTI was then measured at
end-systole as the linear distance between the tri-
cuspid annulus and the end of the right atrial
myocardial sleeve.
All remaining qualitative analyses were per-
formed online during the acquisition of real-time
3-dimensional images. In particular, the Eustachian
ridge was evaluated as either prominent or normal,
while the Eustachian valve was judged as promi-
nent, moderate, or unremarkable. The presence of a
septal recess was recorded, and it was assessed as
large (when the recess extended to reach the mid-
CVTI), regular, or absent. Finally, encroachment of
pectinate muscles into the CVTI was determined
and reported as abundant, of moderate extent, or
absent (Figs. 2 and 3).
Reproducibility of echocardiographic analysis. The
datasets of 10 patients were randomly selected and
analyzed again 3 months later by the original
observer and by a second observer who was blinded
to the results of the previous analysis. Intraobserver
and interobserver agreement was assessed for the
quantitative measurements of CVTI length and for
llows visualization of anatomical details of the cavotricuspid isth-
mus; EV  Eustachian valve; LAO  left anterior oblique;EE) a
isthcava; TV  tricuspid valve.
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719the qualitative evaluations of the Eustachian ridge,
Eustachian valve, septal recess or pouch, and pec-
tinate muscles.
Statistics. Continuous variables are expressed as
ean  SD or as median (interquartile range
[IQR]) if appropriate. Normally distributed data
were compared using independent Student t tests.
Otherwise, comparisons between groups were per-
formed using Mann-Whitney U tests. Categorical
values are stated as absolute and relative frequencies
and were compared using Fisher exact tests. All
tests were 2 tailed.
Intraobserver and interobserver agreement in the
measurements of CVTI length was assessed using
Bland-Altman analysis and expressed as the mean
difference between the 2 measurements  2 SDs.
For qualitative evaluation of anatomical features
such as the Eustachian valve, kappa statistics were
used, and the level of agreement was interpreted as
follows: 0 to 0.2 poor to slight, 0.21 to 0.4 fair,
0.41 to 0.6  moderate, 0.61 to 0.8  substantial,
and 0.81 to 1.0 nearly perfect. A linear regression
model for either fluoroscopy time or dose was fitted,
including ablation time (log-transformed), group,
and their interaction. Stata version 11 (StataCorp
Figure 2. Prominent Anatomical Features of the CVTI
Prominent features include pectinate muscles encroaching from th
and septal recess (yellow asterisks in B). FO  foramen ovale; othLP, College Station, Texas) was used for compu-tation. A p value 0.05 was considered statistically
significant.
R E S U L T S
Comparison of the baseline characteristics between
the 2 groups is presented in Table 1. Patients in the
control group were significantly older than those in
the RT3DTEE group and presented a trend toward
slightly lower left ventricular ejection fractions. The
prevalence of atrial fibrillation, however, was higher
in the RT3DTEE group.
Reproducibility of echocardiographic analysis. Intrao-
server and interobserver agreement for the mea-
urement of CVTI length was good; according to
land-Altman analysis, the mean differences  2
Ds for CVTI length were 1.6  4.0 mm and
.8  7.0 mm, respectively.
Intraobserver and interobserver agreement for
he qualitative evaluation of the Eustachian ridge
kappa  1.0 for both), Eustachian valve (kappa 
1.0 for both), septal recess or pouch (kappa  0.80
for both), and pectinate muscles (kappa  1.0 and
0.80, respectively) was nearly perfect.
Feasibility of RT3DTEE to visualize the CVTI. In all but
1 patient (5%), intraprocedural visualization of the
sta terminalis (yellow asterisks in A), prominent Eustachian valve,
breviations as in Figure 1.e criCVTI was possible. The reason for failure was a
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720prominent aortic bulb with a marked protrusion
into a small-sized right atrium. In the remaining 20
patients, CVTI imaging was always possible, and
visualization was considered of good quality in most
cases (75%). The median length of the CVTI was
40 mm; in 11 patients (55%), CVTI length was
higher than the median value, and it was therefore
labeled “long CVTI.” With the exception of 2
patients (10%) in whom the CVTIs were found to
be morphologically normal, the other 18 patients
(90%) presented at least 1 prominent anatomical
feature (Table 2).
Feasibility of RT3DTEE to visualize the ablation
catheter. RT3DTEE allowed visualization of the
apping catheter when moved from the septal to
he lateral position and vice versa (Fig. 4A). Typical
rag movement (anterior to posterior movement
long the CVTI) could be equally appreciated;
owever, limited visibility of the catheter tip was
ncountered when the tip reached the proximal
ortion of the CVTI, before entering the inferior
ena cava. Visualization of catheter tip contact was
ossible with RT3DTEE in many patients (50%)
ut was limited by 2 key factors, namely, different
coustic resonance yielded by different catheter
anufacturers (Fig. 4A) and acoustic shadowing of
he catheter due to the artifact beam (Fig. 4B).
Figure 3. Features of the Septal Portion of the CVTI
A frequently encountered anatomical feature of the cavotricuspid isthm
Anterior insertion of the valve in the septum may produce a deephese difficulties could be corrected by gentle rota-ion of the ultrasound probe and adjustment of
coustic gain and cropping or by selecting 1 partic-
lar catheter manufacturer (Online Video 1).
Efﬁcacy and safety of the RT3DTEE-guided approach
for ablation. Achievement of bidirectional CVTI
block was possible in all patients regardless of the
monitoring approach (fluoroscopy or RT3DTEE).
Patients monitored by RT3DTEE had significantly
shorter procedural times and were exposed to sig-
nificantly less radiation. Also, a smaller median
number of RF applications was needed to achieve
bidirectional block compared to the control group
(Table 3). The association between radiation expo-
sure and ablation time (Fig. 5) was not different
when comparing the control and RT3DTEE
groups (nonsignificant interaction). On bivariate
analysis, both ablation time and group were
significantly (both p values 0.001) and indepen-
dently associated with fluoroscopy time and dose,
with markedly lower values for the RT3DTEE
group.
As experience with RT3DTEE increased, pro-
cedural and fluoroscopy times further reduced in the
last 10 cases compared with the first 10 cases, thus
indicating a strong learning curve effect (Table 2,
Fig. 6). Of note, significant reduction of RFA time
was observed in the last RT3DTEE subgroup
(CVTI) is a prominent Eustachian valve (red arrows in A and B).
al recess (yellow asterisks in B).us(median 7.0 min, IQR 6.4 to 8.4 min) compared
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721with the control group (median 11.7 min, IQR 8.0 to
20.0 min) (p  0.036). In 8 of the 9 patients (89%)
ith complex CVTI anatomy (multiple prominent
eatures), CVTI conduction block was obtained by
blating along the inferolateral isthmus line.
No major or minor complications ensued from
he ablation procedure in either group.
D I S C U S S I O N
To the best of our knowledge, ours is the first study
to systematically evaluate the use of RT3DTEE to
guide a transcatheter ablation procedure, and it
may therefore be considered as a proof of concept
for the use of RT3DTEE in guiding RFA of
atrial arrhythmias. RT3DTEE reliably visualized
the CVTI in nearly all patients, providing enough
temporal and spatial resolution for tracking abla-
tion catheter movements, thus enabling success-
ful treatment of CVTI-dependent atrial flutter
ablation in all patients. In comparison with the
conventional fluoroscopy-guided approach,
Table 1. Patient Baseline Characteristics
Characteristic
Conventional
(n  49)
RT3DTEE
(n  21)
Men 41 18
Age (yrs) 68.3 9.4 61.3 12.5*
Hypertension 29 9
Coronary artery disease 24 6
Valve disease 6 3
Other CV disease 13 6
“Lone” atrial ﬂutter 6 3
COPD 3 2
Left atrial diameter (mm) 43.8 9.4 43.5 8.9
LVEF (%) 48.9 17.3 56.4 13.2
Paroxysmal atrial ﬂutter 18 11
Persistent atrial ﬂutter 30 11
History of atrial ﬁbrillation 15 14†
Treatment with AA drugs
Amiodarone 15 4
Sotalol 3 1
Class IC AA drugs 1 1
Beta-blockers 30 15
Digitalis 2 0
Calcium channel blockers 1 0
ACE inhibitors/ARBs 30 11
Diuretic agents 21 4
Statins 27 7
Values are n or mean  SD. *Signiﬁcant difference for age (p  0.02).
†Difference in the prevalence of atrial ﬁbrillation (p  0.03).
AA  antiarrhythmic; ACE  angiotensin-converting enzyme; ARB 
angiotensin receptor blocker; CV  cardiovascular; COPD  chronic obstruc-
tive pulmonary disease; LVEF  left ventricular ejection fraction; RT3DTEE 
real-time 3-dimensional transesophageal echocardiography.RT3DTEE was equally effective in achievingconduction block across the CVTI, with a smaller
number of RF applications, and entailed a signif-
icant reduction of radiation exposure and proce-
dural time.
Anatomical characterization of the CVTI in patients
with typical common atrial ﬂutter. Anatomic data on
he CVTI from autopsy (13) and from cardiac
omputed tomographic (14) evaluations in general
atient cohorts without specific atrial arrhythmic
onditions have described a high anatomical heter-
geneity of this structure. More specifically, data on
he characterization of CVTI anatomy in patients
ith common atrial flutter are derived mostly from
ngiography of the right atrium (15,16). The major
dvantage of RT3DTEE is the ability to precisely
valuate anatomical and morphological characteris-
ics in vivo and in real time. In the patient cohort of
his study with atrial flutter, RT3DTEE confirmed
hat the CVTI is a complex and heterogenous
tructure. The incidence of prominent Eustachian
idge and valve (60%) was greater than in the
eneral population (20% [14]) but in line with other
tudies performed in patients with common atrial
utter (15). Moreover, in this study, prominent
ustachian ridge and valve, a medial recess, and the
resence of pectinate muscles sometimes coexisted
20%). This finding emphasizes that structural and
orphological heterogeneity may represent an im-
ortant arrhythmogenic substrate for triggering and
aintaining macroreentry.
Improving navigation along the CVTI while reducing
procedural time. Constant efforts have been ori-
ented toward rendering procedural time for CVTI
ablation more predictable (3–7,15,17–22) (Table 4). A
number of studies have explored the importance of
adequate structural characterization through either
angiography (15,16), magnetic resonance imaging
(7,23), or the use of nonfluoroscopic mapping
techniques (5,6,21). Assessment of remote mag-
netic navigation has also been investigated, yielding
Table 2. Distribution of Prominent CVTI Anatomical Features in
(n  20) and Divided According to the Two Patient Subgroups
Last 10 Patients) Treated With the RT3DTEE-Guided Approach
Anatomical Feature All Patients First 1
Long CVTI 11 6
Prominent Eustachian ridge 9 3
Prominent Eustachian valve 6 4
Deep septal recess 8 5
Presence of pectinate muscle 10 3
Patients with 3 or more features 9 5
CVTI  cavotricuspid isthmus; RT3DTEE  real-time 3-dimensional transesophaAll Patients
(First 10 and
0 Last 10
5
6
2
3
7
4
geal
echocardiography.
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722only modest results, because this technique, while
reducing radiation exposure, increases RF applica-
tion time (3,4).
RT3DTEE allowed the simultaneous and imme-
diate characterization of the CVTI, and in most
cases with complex “septal” anatomy (8 of 20
patients), an inferolateral line was performed to
obtain CVTI block (Fig. 7, Online Video 2)
(14,16,24,25). A prominent Eustachian valve was
almost always associated with a prominent Eusta-
chian ridge. Other important obstacles were con-
sidered to be the length of the isthmus (7,15,22) as
well as the CVTI–to–inferior vena cava angle (7).
With regard to the latter feature, our preliminary
experience with nonquantitative RT3DTEE did
not assess the CVTI–to–inferior vena cava angle in
real time.
Table 3. Procedural Data
Variable
Conventional
(n  49)
Total procedural time (min) 115.0 (85.0–133.0)
Fluoroscopy time (min) 19.3 (12.9–36.0)
Fluoroscopy dose (cGy·cm2) 3,520.7 (1,700.0–6,7
Number of RF applications 12 (10–22)
Ablation time (min) 11.7 (8.0–20.0)
Values are median (interquartile range).
Figure 4. Visualization of Ablation Catheter Contact and Localiz
The catheter is viewed along the lateral, central, and medial portion
ablation catheter, with closely intercalated electrodes (left), and pla
appreciated. Please see Online Video 1.RF  radiofrequency; RT3DTEE  real-time 3-dimensional transesophageal echocaAs observed, the learning curve associated with the
novel approach played a role. This was shown by
reduced dispersion of procedural times, radiation ex-
posure, and ablation times, defined as a narrowing of
the IQR around the median values in the latter cases
(Fig. 6). This suggests that RT3DTEE may render
procedural time highly predictable and RF delivery
more precise, because ablation of the CVTI is per-
formed by circumventing anatomic obstacles.
Reduction of biological risk from radiation exposure.
The excitement generated by cardiovascular im-
aging has recently been tempered by a string of
high-impact publications (26 –30) that have
raised concerns about increased medical proce-
dure radiation exposure and the potential risk for
cancer. Most atrial arrhythmias are not life
threatening, and the procedural purpose is mostly
RT3DTEE
(n  20) p Value
73.0 (60.0–91.0) 0.001
4.2 (3.1–8.4) 0.001
) 575.4 (438.5–1,299.4) 0.001
7 (6–10) 0.007
8.7 (6.5–14.6) 0.145
n
f the cavotricuspid isthmus (A). (B) Differences between gold-tip
m-iridium catheter from a different manufacturer (middle) may be09.0atio
s o
tinurdiography.
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723improvement in quality of life. In this view, the
potential curative intent should be weighed
against procedural success rate, risk for compli-
cations, and the long-term risk for a biological
effect. Thus, following the principle of “as low as
Figure 5. Plotting of Procedural Data of the Two Study Groups
For real-time 3-dimensional transesophageal echocardiography (RT3
roscopy time (A) and dose (B) are correlated to ablation time.
Figure 6. Box Plot for Procedural Data
Midline: median; box: 25th to 75th percentiles; whiskers: nonoutlie
red lines refer to the highest and lowest mean values from publish
3-dimensional transesophageal echocardiography.reasonably achievable,” which has guided the U.S.
Food and Drug Administration’s approval process
and developments in the field of cardiac imaging,
our data show that RT3DTEE may well serve this
goal (31). RT3DTEE resulted in at least a 3-fold
E) (red circles) and control (CON) (green squares) groups, ﬂuo-
tremes; dots: outlier values. Upper and lower horizontal dashed
esearch (for details, refer to Table 4). RT3DTEE  real-timeDTEr ex
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724reduction in radiation exposure compared with the
conventional fluoroscopy-assisted approach.
The reduction in fluoroscopy time observed dur-
ing RT3DTEE was greater than that obtained with
either the remote magnetic (3,4) or the electroanat-
omically guided (21) approach. In the latter case,
mean fluoroscopy time was approximately 8 min, and
as with RT3DTEE, the use of fluoroscopy was
limited to the diagnostic part of the procedure,
Figure 7. Radiofrequency Ablation in the Presence
of a Septal Recess
In some cases with prominent septal recesses, radiofrequency
energy delivery was applied by targeting the lateral border of
the recess, and cavotricuspid isthmus conduction block was sub-
sequently obtained. See Online Video 2. EV  Eustachian valve;
cedural Data Derived From Other Studies on CVTI Ablation Usin
atheter
n
Procedure Time
(min)
Fluoroscopy Time
(min)
24 75 27 22 6.3
40 172.5 47.4 29.2 9.4
100 119 50 26 14.8
50 / 15.7 10.7
24 / 15.9 10.6
281 72 26 14.3 13.0
25 79.2 30.6 8.2 4.6
183 197 45 45 25
105 88 54 14.8 11.9
45 77 24 15.0 4.1
26 195 19 29.0 4.0
16 73.1 15 7.1 3.8
or median (interquartile range).
mus; RF  radiofrequency; RFA  radiofrequency ablation.r
P  septal pouch.whereas ablation was guided mainly by navigation
without fluoroscopy.
Issues and challenges in the use of RT3DTEE for
monitoring catheter ablation procedures. The find-
ngs of this study substantiate the expanding role
f RT3DTEE from a diagnostic modality to a
ool for monitoring invasive procedures. Com-
ared with other interventional cardiologic pro-
edures (percutaneous valve repair or replace-
ent, closure of atrial and ventricular defects, left
trial appendage closure), standard electrophysi-
logical and ablation procedures possess many
articularities. The relatively rapid catheter
ovement, the relatively narrow visualization
eld at an acceptable high frame rate (25 Hz),
nd metallic artifacts due to the large catheter tip
ay all represent technical challenges for routine
doption of the technique. In addition, the finding
hat different ablation catheter manufacturers present
ifferent acoustic impedance suggests that some cath-
ters are more ultrasound compatible than others; this
ssue merits further investigation. Despite these chal-
enges and the burden involved in using RT3DTEE
o monitor an electrophysiological procedure, there
re certain situations, such as pregnancy or in younger
atients, in which a strong incentive to reduce harmful
adiation exposure while minimizing procedural risks
xists. To this end, the finding that RT3DTEE may
eliably and effectively monitor an ablation procedure
ith only a short associated learning curve may be
nteresting and helpful. Finally, RT3DTEE may pro-
ide a unique way to further define key anatomical
tructures responsible for a macroreentry in the CVTI
e Conventional Fluoroscopy-Guided Approach
roscopy Dose
(cGy·cm2)
RF Application Time
(min)
Number of RF
Applications
15.0 6.2 10 5
16.7 6.5
2.3 2.5
39 27 12.9 8.6
,100 1,980
15.0 15.0
5.4 3.6
3 (3,435–5,862) 7.5 3.4 9 (6–16)
21.0 7.0 14 (2–41)
8.0 5.2 6.6 3.1Table 4. Principal Pro g th
With an 8-mm RFA C
Study (Ref. #)
Fluo
Kottkamp et al. (5)
Willems et al. (6)
Heidbüchel et al. (15)
Schreieck et al. (17)
Schneider et al. (18) 2
Da Costa et al. (22)
Steven et al. (3)
Kim et al. (19)
Hindricks et al. (21)
Vollmann et al. (4) 4,30
Kirchhof et al. (7)
Kardos et al. (20)
Values are n, mean  SD,egion.
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725Study limitations. This study was a pilot, single-
enter, nonrandomized study with a relatively small
atient population. The RT3DTEE approach was
epresented by the need for general anesthesia,
hich lengthened overall procedural duration and
ould potentially increase risk; such a limitation
ay be overcome in the future when small-sized
ransesophageal echocardiographic probes become
vailable (32). Also, general anesthesia and the use
f mild sedation and pain control medication in
he conventional approach to limit patient pain
nd movement may each have effects on proce-
ural outcome data. For this reason, in the
omputation of the number of RF lesions and
ime of ablation, only RF applications lasting
60 s were considered.
RT3DTEE assessment of CVTI anatomy was
ostly qualitative. Clearly, a validation process with
ther imaging modalities is needed. Despite some
odest baseline differences between the 2 study
roups, it is unlikely that these may have influenced
cute procedural outcomes. More studies arewith common-type atrial flutter. Circ
1
time three-dimensiomical and morphological features, clinical vari-
bles, and their influence on CTVI ablation.
C O N C L U S I O N S
This study has demonstrated that RT3DTEE-
guided ablation of the CVTI is feasible, yielding
comparable acute efficacy to the standard
fluoroscopy-guided approach. This imaging mo-
dality conferred high-resolution images, allowing
navigation without fluoroscopy and precise RF
delivery in target anatomical areas of the CVTI,
thus allowing considerable reductions of proce-
dural time, radiation exposure, and the number of
RFA applications. Further investigations are
needed to explore this new promising anatomi-
cally driven, fluoroscopy-free navigation ap-
proach for guiding the ablative treatment of
cardiac arrhythmias.
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